Evidence map›Paper›PMID 39858297›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Towards New Scaffolds for Antimicrobial Activity-In Silico/In Vitro Workflow Introducing New Lead Compounds.

Maria Mangana, George Lambrinidis, Ioannis K Kostakis, Ioanna Kalpaktsi, Marina Sagnou, Chrysoula Nicolaou, Emmanuel Mikros, Stylianos Chatzipanagiotou, Anastasios Ioannidis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. OverallFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maria ManganaDepartment of Clinical Microbiology, Athens Medical School, Aeginition Hospital, 11528 Athens, Greece.
George LambrinidisDivision of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15771 Athens, Greece.ORCID 0000-0002-2820-9338
Ioannis K KostakisDivision of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15771 Athens, Greece.ORCID 0000-0002-9901-5223
Ioanna KalpaktsiDivision of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15771 Athens, Greece.
Marina SagnouInstitute of Biosciences & Application, NCSR "Demokritos", 15310 Athens, Greece.ORCID 0000-0002-4231-6658
Chrysoula NicolaouDepartment of Clinical Microbiology, Athens Medical School, Aeginition Hospital, 11528 Athens, Greece.
Emmanuel MikrosDivision of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15771 Athens, Greece.ORCID 0000-0002-5984-5169
Stylianos ChatzipanagiotouDepartment of Clinical Microbiology, Athens Medical School, Aeginition Hospital, 11528 Athens, Greece.ORCID 0000-0002-1251-8355
Anastasios IoannidisDepartment of Nursing, Faculty of Health Sciences, University of Peloponnese, 22100 Tripolis, Greece.ORCID 0000-0003-1880-7366

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial activitychemical librarieslead optimizationligand-based drug designmultidrug-resistant bacteria

Identifiers

PMID39858297
PMCPMC11763081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.